There are 2949 resources available
1782MO - Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC
Presenter: Hye Ryun Kim
Session: Mini Oral - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1895MO - Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma
Presenter: Hidetoshi Hayashi
Session: Mini Oral - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
1896MO - Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
Presenter: Daniel C. Christoph
Session: Mini Oral - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
4MO - A novel AI solution for auto-segmentation of multi-origin liver neoplasms
Presenter: Akshayaa Vaidyanathan
Session: Mini Oral - Basic Science
Resources:
Abstract
Slides
Webcast
Invited Discussant 86MO, 87MO and LBA10
Presenter: Michael Speicher
Session: Mini Oral - Translational research
Resources:
Slides
Webcast
Invited Discussant 88MO, 1931MO, 1932MO and 1933MO
Presenter: Teresa Davoli
Session: Mini Oral - Translational research
Resources:
Slides
Webcast
Open & welcome
Presenter: Daniel Peeper
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast
Invited Discussant 4MO and 5MO
Presenter: Stefano Trebeschi
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast
Invited Discussant 7MO, 8MO, 1978MO and 1979MO
Presenter: Daniel Peeper
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast
Invited Discussant 6MO, 1980MO and 9MO
Presenter: Ruth Palmer
Session: Mini Oral - Basic Science
Resources:
Slides
Webcast